Reports of Biochemistry
and Molecular Biology
Fri, Apr 19, 2024
[Archive]
Volume 11, Issue 2 (Vol.11 No.2 Jul 2022)
rbmb.net 2022, 11(2): 246-251 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ziaeemehr A, Sharebiani H, Taheri H, Fazeli B. Secondary Infertility: A Neglected Aspect of Buerger’s Disease. rbmb.net 2022; 11 (2) :246-251
URL: http://rbmb.net/article-1-843-en.html
URL: http://rbmb.net/article-1-843-en.html
Immunology Research Center, Inflammation and Inflammatory Diseases Division, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. & Vascular Independent Research and Education, European Foundation. Milan, Italy.
Abstract: (1842 Views)
Background: During the gathering of demographic data for the biobank on Buerger’s Disease (BD), we found that, after the clinical manifestation of BD, the patients usually became infertile, and the age of their last child was compatible with the time of disease diagnosis. The aim of this study was to evaluate the underlying cause of secondary infertility in BD patients.
Methods: Anti-sperm antibodies (ASA), testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in the sera of 39 male BD patients were measured and compared with 39 age-matched Caucasian male controls.
Results: Six patients declared that they suffered from impotency. The ASA level was positive in 25.6% of the patients and 2.4% of the controls (p= 0.003, CC= 6.96). The mean levels of testosterone in the patients and controls were 393.12±32.9 ng/dl and 354.37±30.9 ng/dl, respectively. The mean levels of LH in the patients and controls were 0.88±0.12 mIU/r and 0.85±0.1 mIU/r, respectively. The mean levels of FSH in the patients and controls were 4.1± 0.35 mIU/r and 3.56±0.33 mIU/r, respectively. No significant difference in the serum levels of testosterone, LH, or FSH was found between the patients and controls (p> 0.05). The spermograms of three ASA-negative patients demonstrated impaired sperm motility.
Conclusions: Anti-sperm antibodies, disturbed genital circulation, autonomic dysfunction and sperm motility may be responsible for secondary infertility in Buerger’s Disease.
Methods: Anti-sperm antibodies (ASA), testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in the sera of 39 male BD patients were measured and compared with 39 age-matched Caucasian male controls.
Results: Six patients declared that they suffered from impotency. The ASA level was positive in 25.6% of the patients and 2.4% of the controls (p= 0.003, CC= 6.96). The mean levels of testosterone in the patients and controls were 393.12±32.9 ng/dl and 354.37±30.9 ng/dl, respectively. The mean levels of LH in the patients and controls were 0.88±0.12 mIU/r and 0.85±0.1 mIU/r, respectively. The mean levels of FSH in the patients and controls were 4.1± 0.35 mIU/r and 3.56±0.33 mIU/r, respectively. No significant difference in the serum levels of testosterone, LH, or FSH was found between the patients and controls (p> 0.05). The spermograms of three ASA-negative patients demonstrated impaired sperm motility.
Conclusions: Anti-sperm antibodies, disturbed genital circulation, autonomic dysfunction and sperm motility may be responsible for secondary infertility in Buerger’s Disease.
Type of Article: Original Article |
Subject:
Immunology
Received: 2021/12/25 | Accepted: 2021/12/25 | Published: 2022/08/7
Received: 2021/12/25 | Accepted: 2021/12/25 | Published: 2022/08/7
References
1. Fazeli B, Poredos P, Patel M, Klein-Weigel P, Catalano M, et al. Milestones in thromboangiitis obliterans: a position paper of the VAS-European independent foundation in angiology/vascular medicine. Int Angiol. 2021;40(5):395-408. [DOI:10.23736/S0392-9590.21.04712-X] [PMID]
2. Fazeli B. Buerger's disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of Iran. Arch Med Sci. 2010;6(3):343-7. [DOI:10.5114/aoms.2010.14253] [PMID] [PMCID]
3. Fazeli B, Ligi D, Keramat S, Maniscalco R, Sharebiani H, Mannello F. Recent Updates and Advances in Winiwarter-Buerger Disease (Thromboangiitis Obliterans): Biomolecular Mechanisms, Diagnostics and Clinical Consequences. Diagnostics (Basel). 2021;11(10):1736. [DOI:10.3390/diagnostics11101736] [PMID] [PMCID]
4. Yeap BB. Androgens and cardiovascular disease. Curr Opin Endocrinol Diabetes Obes. 2010;17(3):269-276. [DOI:10.1097/MED.0b013e3283383031] [PMID]
5. Singh K, Sood S. Autonomic functions in Buerger's disease. Indian J Physiol Pharmacol. 2001;45(4):470-4.
6. Kuwahara M, Matsushita K, Nakamura K, Yoshinaga H, Aki M, Fujisaki N, et al. (Thromboangiitis obliterans of the spermatic cord: a case report). Hinyokika kiyo. 1993;39(4):369-72.
7. Brehmer-Andersson E, Andersson L, Johansson JE. Hemorrhagic infarctions of testis due to intimal fibroplasia of spermatic artery. Urology. 1985;25(4):379-82. [DOI:10.1016/0090-4295(85)90493-5]
8. Fakour F, Fazeli B. Visceral bed involvement in thromboangiitis obliterans: a systematic review. Vasc Health Risk Manag. 2019;15:317-353. [DOI:10.2147/VHRM.S182450] [PMID] [PMCID]
9. Mazumdar S, Levine AS. Antisperm antibodies: etiology, pathogenesis, diagnosis, and treatment. Fertility and sterility. 1998;70(5):799-810. [DOI:10.1016/S0015-0282(98)00302-1]
10. Heidenreich A, Bonfig R, Wilbert DM, Strohmaier WL, Engelmann UH. Risk factors for antisperm antibodies in infertile men. Am J Reprod Immunol. 1994;31(2-3):69-76. [DOI:10.1111/j.1600-0897.1994.tb00849.x] [PMID]
11. Maduro MR, Lamb DJ. Understanding new genetics of male infertility. J Urol. 2002;168(5):2197-205. [DOI:10.1016/S0022-5347(05)64355-8]
12. Miyaoka R, Esteves SC. A critical appraisal on the role of varicocele in male infertility. Adv Uro. 2012;597495. [DOI:10.1155/2012/597495] [PMID] [PMCID]
13. Sharma R, Biedenharn KR, Fedor JM, Agarwal A. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol. 2013;16;11:66. [DOI:10.1186/1477-7827-11-66] [PMID] [PMCID]
14. Calogero A, Polosa R, Perdichizzi A, Guarino F, La Vignera S, Scarfia A, et al. Cigarette smoke extract immobilizes human spermatozoa and induces sperm apoptosis. Reprod Biomed Online. 2009;19(4):564-71. [DOI:10.1016/j.rbmo.2009.05.004] [PMID]
15. Rossato M, Pagano C, Vettor R. The cannabinoid system and male reproductive functions. J Neuroendocrinol. 2008;20,Suppl1:90-3. [DOI:10.1111/j.1365-2826.2008.01680.x] [PMID]
16. Fleshman K. Buerger's disease in Nepal.Trop Doct. 1998 Oct;28(4):203-6. [DOI:10.1177/004947559802800405] [PMID]
17. Colagar AH, Jorsaraee GA, Marzony ET. Cigarette smoking and the risk of male infertility. Pak J Biol Sci. 2007;10(21):3870-4. [DOI:10.3923/pjbs.2007.3870.3874] [PMID]
18. Vine MF. Smoking and male reproduction: a review. Int J Androl. 1996;19(6):323-37 [DOI:10.1111/j.1365-2605.1996.tb00523.x] [PMID]
19. R Adar, M Z Papa, J Schneiderman. Thromboangiitis obliterans: an old disease in need of a new look. Int J Cardiol. 2000;75 Suppl 1:S167-70; discussion S171-3. [DOI:10.1016/S0167-5273(00)00185-6]
20. Sharebiani H, Fazeli B, Maniscalco R, Ligi D, Mannello F. The Imbalance among Oxidative Biomarkers and Antioxidant Defense Systems in Thromboangiitis Obliterans (Winiwarter-Buerger Disease). J Clin Med. 2020;9(4):1036. [DOI:10.3390/jcm9041036] [PMID] [PMCID]
21. Lwaleed BA, Greenfield R, Stewart A, Birch B, Cooper AJ. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost. 2004;92(4):752-66. [DOI:10.1160/TH04-03-0142] [PMID]
22. Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. World J Mens Health. 2014;32(1):1-17. [DOI:10.5534/wjmh.2014.32.1.1] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
